Global Cell Therapy CMO Production, Demand and Key Producers, 2022-2028
This report studies the global Cell Therapy CMO demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cell Therapy CMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell Therapy CMO that contribute to its increasing demand across many markets.
The global Cell Therapy CMO market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Cell Therapy CMO total market, 2017-2028, (USD Million)
Global Cell Therapy CMO total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Cell Therapy CMO total market, key domestic companies and share, (USD Million)
Global Cell Therapy CMO revenue by player and market share 2017-2022, (USD Million)
Global Cell Therapy CMO total market by Type, CAGR, 2017-2028, (USD Million)
Global Cell Therapy CMO total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Cell Therapy CMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Charles River, The Discovery Labs, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies, Exothera, WuXi AppTec, Pharmaron, OBiO and Cell Therapies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell Therapy CMO market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Cell Therapy CMO Market, By Region:
1. How big is the global Cell Therapy CMO market?
2. What is the demand of the global Cell Therapy CMO market?
3. What is the year over year growth of the global Cell Therapy CMO market?
4. What is the total value of the global Cell Therapy CMO market?
5. Who are the major players in the global Cell Therapy CMO market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for Cell Therapy CMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell Therapy CMO that contribute to its increasing demand across many markets.
The global Cell Therapy CMO market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Cell Therapy CMO total market, 2017-2028, (USD Million)
Global Cell Therapy CMO total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Cell Therapy CMO total market, key domestic companies and share, (USD Million)
Global Cell Therapy CMO revenue by player and market share 2017-2022, (USD Million)
Global Cell Therapy CMO total market by Type, CAGR, 2017-2028, (USD Million)
Global Cell Therapy CMO total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Cell Therapy CMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Charles River, The Discovery Labs, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies, Exothera, WuXi AppTec, Pharmaron, OBiO and Cell Therapies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell Therapy CMO market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Cell Therapy CMO Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Stem Cell
- Non-Stem Cell
- Commercial
- Academic Research
- Others
- Charles River
- The Discovery Labs
- BIOCENTRIQ
- FUJIFILM Diosynth Biotechnologies
- Exothera
- WuXi AppTec
- Pharmaron
- OBiO
- Cell Therapies
- AGC Biologics
- Cytiva
- Helixmith
- ThermoGenesis
- Anemocyte
- Thermo Fisher Scientific
- CBM
- Bio Elpida
- Genezen
- CCRM
- RoslinCT
- GenScript ProBio
1. How big is the global Cell Therapy CMO market?
2. What is the demand of the global Cell Therapy CMO market?
3. What is the year over year growth of the global Cell Therapy CMO market?
4. What is the total value of the global Cell Therapy CMO market?
5. Who are the major players in the global Cell Therapy CMO market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Cell Therapy CMO Introduction
1.2 World Cell Therapy CMO Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Cell Therapy CMO Total Market by Region
1.3.1 World Cell Therapy CMO Market Size by Region (2017-2028)
1.3.2 United States Cell Therapy CMO Market Size (2017-2028)
1.3.3 China Cell Therapy CMO Market Size (2017-2028)
1.3.4 Europe Cell Therapy CMO Market Size (2017-2028)
1.3.5 Japan Cell Therapy CMO Market Size (2017-2028)
1.3.6 South Korea Cell Therapy CMO Market Size (2017-2028)
1.3.7 ASEAN Cell Therapy CMO Market Size (2017-2028)
1.3.8 India Cell Therapy CMO Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cell Therapy CMO Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cell Therapy CMO Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD CELL THERAPY CMO COMPANIES COMPETITIVE ANALYSIS
2.1 World Cell Therapy CMO Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Cell Therapy CMO Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Cell Therapy CMO in 2021
2.2.3 Global Concentration Ratios (CR8) for Cell Therapy CMO in 2021
2.3 Cell Therapy CMO Company Evaluation Quadrant
2.4 Cell Therapy CMO Market: Overall Company Footprint Analysis
2.4.1 Cell Therapy CMO Market: Region Footprint
2.4.2 Cell Therapy CMO Market: Company Product Type Footprint
2.4.3 Cell Therapy CMO Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Cell Therapy CMO Market Comparison
3.1.1 United States VS China: Cell Therapy CMO Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Cell Therapy CMO Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Cell Therapy CMO Major Players and Market Share, 2017-2022
3.2.1 Major Players of Cell Therapy CMO in United States, Headquarters (States, Country)
3.2.2 United States Cell Therapy CMO Revenue by Domestic Player, (2017-2022)
3.3 China Cell Therapy CMO Major Players and Market Share, 2017-2022
3.3.1 Major Players of Cell Therapy CMO in China, Headquarters (Province, Country)
3.3.2 China Cell Therapy CMO Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Cell Therapy CMO Major Players and Market Share, 2017-2022
3.4.1 Major Players of Cell Therapy CMO in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Cell Therapy CMO Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Cell Therapy CMO Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Stem Cell
4.2.2 Non-Stem Cell
4.3 Market Segment by Type
4.3.1 World Cell Therapy CMO Market Size by Type (2017-2022)
4.3.2 World Cell Therapy CMO Market Size by Type (2023-2028)
4.3.3 World Cell Therapy CMO Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Cell Therapy CMO Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Commercial
5.2.2 Academic Research
5.2.3 Others
5.3 Market Segment by Application
5.3.1 World Cell Therapy CMO Market Size by Application (2017-2022)
5.3.2 World Cell Therapy CMO Market Size by Application (2023-2028)
5.3.3 World Cell Therapy CMO Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Charles River
6.1.1 Charles River Details
6.1.2 Charles River Major Business
6.1.3 Charles River Cell Therapy CMO Product and Services
6.1.4 Charles River Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Charles River Recent Developments/Updates
6.1.6 Charles River Competitive Strengths & Weaknesses
6.2 The Discovery Labs
6.2.1 The Discovery Labs Details
6.2.2 The Discovery Labs Major Business
6.2.3 The Discovery Labs Cell Therapy CMO Product and Services
6.2.4 The Discovery Labs Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 The Discovery Labs Recent Developments/Updates
6.2.6 The Discovery Labs Competitive Strengths & Weaknesses
6.3 BIOCENTRIQ
6.3.1 BIOCENTRIQ Details
6.3.2 BIOCENTRIQ Major Business
6.3.3 BIOCENTRIQ Cell Therapy CMO Product and Services
6.3.4 BIOCENTRIQ Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 BIOCENTRIQ Recent Developments/Updates
6.3.6 BIOCENTRIQ Competitive Strengths & Weaknesses
6.4 FUJIFILM Diosynth Biotechnologies
6.4.1 FUJIFILM Diosynth Biotechnologies Details
6.4.2 FUJIFILM Diosynth Biotechnologies Major Business
6.4.3 FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Product and Services
6.4.4 FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
6.4.6 FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
6.5 Exothera
6.5.1 Exothera Details
6.5.2 Exothera Major Business
6.5.3 Exothera Cell Therapy CMO Product and Services
6.5.4 Exothera Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Exothera Recent Developments/Updates
6.5.6 Exothera Competitive Strengths & Weaknesses
6.6 WuXi AppTec
6.6.1 WuXi AppTec Details
6.6.2 WuXi AppTec Major Business
6.6.3 WuXi AppTec Cell Therapy CMO Product and Services
6.6.4 WuXi AppTec Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 WuXi AppTec Recent Developments/Updates
6.6.6 WuXi AppTec Competitive Strengths & Weaknesses
6.7 Pharmaron
6.7.1 Pharmaron Details
6.7.2 Pharmaron Major Business
6.7.3 Pharmaron Cell Therapy CMO Product and Services
6.7.4 Pharmaron Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 Pharmaron Recent Developments/Updates
6.7.6 Pharmaron Competitive Strengths & Weaknesses
6.8 OBiO
6.8.1 OBiO Details
6.8.2 OBiO Major Business
6.8.3 OBiO Cell Therapy CMO Product and Services
6.8.4 OBiO Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 OBiO Recent Developments/Updates
6.8.6 OBiO Competitive Strengths & Weaknesses
6.9 Cell Therapies
6.9.1 Cell Therapies Details
6.9.2 Cell Therapies Major Business
6.9.3 Cell Therapies Cell Therapy CMO Product and Services
6.9.4 Cell Therapies Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 Cell Therapies Recent Developments/Updates
6.9.6 Cell Therapies Competitive Strengths & Weaknesses
6.10 AGC Biologics
6.10.1 AGC Biologics Details
6.10.2 AGC Biologics Major Business
6.10.3 AGC Biologics Cell Therapy CMO Product and Services
6.10.4 AGC Biologics Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 AGC Biologics Recent Developments/Updates
6.10.6 AGC Biologics Competitive Strengths & Weaknesses
6.11 Cytiva
6.11.1 Cytiva Details
6.11.2 Cytiva Major Business
6.11.3 Cytiva Cell Therapy CMO Product and Services
6.11.4 Cytiva Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 Cytiva Recent Developments/Updates
6.11.6 Cytiva Competitive Strengths & Weaknesses
6.12 Helixmith
6.12.1 Helixmith Details
6.12.2 Helixmith Major Business
6.12.3 Helixmith Cell Therapy CMO Product and Services
6.12.4 Helixmith Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 Helixmith Recent Developments/Updates
6.12.6 Helixmith Competitive Strengths & Weaknesses
6.13 ThermoGenesis
6.13.1 ThermoGenesis Details
6.13.2 ThermoGenesis Major Business
6.13.3 ThermoGenesis Cell Therapy CMO Product and Services
6.13.4 ThermoGenesis Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 ThermoGenesis Recent Developments/Updates
6.13.6 ThermoGenesis Competitive Strengths & Weaknesses
6.14 Anemocyte
6.14.1 Anemocyte Details
6.14.2 Anemocyte Major Business
6.14.3 Anemocyte Cell Therapy CMO Product and Services
6.14.4 Anemocyte Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 Anemocyte Recent Developments/Updates
6.14.6 Anemocyte Competitive Strengths & Weaknesses
6.15 Thermo Fisher Scientific
6.15.1 Thermo Fisher Scientific Details
6.15.2 Thermo Fisher Scientific Major Business
6.15.3 Thermo Fisher Scientific Cell Therapy CMO Product and Services
6.15.4 Thermo Fisher Scientific Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 Thermo Fisher Scientific Recent Developments/Updates
6.15.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
6.16 CBM
6.16.1 CBM Details
6.16.2 CBM Major Business
6.16.3 CBM Cell Therapy CMO Product and Services
6.16.4 CBM Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.16.5 CBM Recent Developments/Updates
6.16.6 CBM Competitive Strengths & Weaknesses
6.17 Bio Elpida
6.17.1 Bio Elpida Details
6.17.2 Bio Elpida Major Business
6.17.3 Bio Elpida Cell Therapy CMO Product and Services
6.17.4 Bio Elpida Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.17.5 Bio Elpida Recent Developments/Updates
6.17.6 Bio Elpida Competitive Strengths & Weaknesses
6.18 Genezen
6.18.1 Genezen Details
6.18.2 Genezen Major Business
6.18.3 Genezen Cell Therapy CMO Product and Services
6.18.4 Genezen Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.18.5 Genezen Recent Developments/Updates
6.18.6 Genezen Competitive Strengths & Weaknesses
6.19 CCRM
6.19.1 CCRM Details
6.19.2 CCRM Major Business
6.19.3 CCRM Cell Therapy CMO Product and Services
6.19.4 CCRM Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.19.5 CCRM Recent Developments/Updates
6.19.6 CCRM Competitive Strengths & Weaknesses
6.20 RoslinCT
6.20.1 RoslinCT Details
6.20.2 RoslinCT Major Business
6.20.3 RoslinCT Cell Therapy CMO Product and Services
6.20.4 RoslinCT Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.20.5 RoslinCT Recent Developments/Updates
6.20.6 RoslinCT Competitive Strengths & Weaknesses
6.21 GenScript ProBio
6.21.1 GenScript ProBio Details
6.21.2 GenScript ProBio Major Business
6.21.3 GenScript ProBio Cell Therapy CMO Product and Services
6.21.4 GenScript ProBio Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.21.5 GenScript ProBio Recent Developments/Updates
6.21.6 GenScript ProBio Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Cell Therapy CMO and Key Manufacturers
7.2 Cell Therapy CMO Manufacturing Costs
7.3 Cell Therapy CMO Production Process
7.4 Cell Therapy CMO Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Cell Therapy CMO Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Cell Therapy CMO Typical Distributors
8.3 Cell Therapy CMO Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Cell Therapy CMO Introduction
1.2 World Cell Therapy CMO Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Cell Therapy CMO Total Market by Region
1.3.1 World Cell Therapy CMO Market Size by Region (2017-2028)
1.3.2 United States Cell Therapy CMO Market Size (2017-2028)
1.3.3 China Cell Therapy CMO Market Size (2017-2028)
1.3.4 Europe Cell Therapy CMO Market Size (2017-2028)
1.3.5 Japan Cell Therapy CMO Market Size (2017-2028)
1.3.6 South Korea Cell Therapy CMO Market Size (2017-2028)
1.3.7 ASEAN Cell Therapy CMO Market Size (2017-2028)
1.3.8 India Cell Therapy CMO Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cell Therapy CMO Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cell Therapy CMO Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD CELL THERAPY CMO COMPANIES COMPETITIVE ANALYSIS
2.1 World Cell Therapy CMO Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Cell Therapy CMO Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Cell Therapy CMO in 2021
2.2.3 Global Concentration Ratios (CR8) for Cell Therapy CMO in 2021
2.3 Cell Therapy CMO Company Evaluation Quadrant
2.4 Cell Therapy CMO Market: Overall Company Footprint Analysis
2.4.1 Cell Therapy CMO Market: Region Footprint
2.4.2 Cell Therapy CMO Market: Company Product Type Footprint
2.4.3 Cell Therapy CMO Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Cell Therapy CMO Market Comparison
3.1.1 United States VS China: Cell Therapy CMO Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Cell Therapy CMO Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Cell Therapy CMO Major Players and Market Share, 2017-2022
3.2.1 Major Players of Cell Therapy CMO in United States, Headquarters (States, Country)
3.2.2 United States Cell Therapy CMO Revenue by Domestic Player, (2017-2022)
3.3 China Cell Therapy CMO Major Players and Market Share, 2017-2022
3.3.1 Major Players of Cell Therapy CMO in China, Headquarters (Province, Country)
3.3.2 China Cell Therapy CMO Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Cell Therapy CMO Major Players and Market Share, 2017-2022
3.4.1 Major Players of Cell Therapy CMO in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Cell Therapy CMO Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Cell Therapy CMO Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Stem Cell
4.2.2 Non-Stem Cell
4.3 Market Segment by Type
4.3.1 World Cell Therapy CMO Market Size by Type (2017-2022)
4.3.2 World Cell Therapy CMO Market Size by Type (2023-2028)
4.3.3 World Cell Therapy CMO Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Cell Therapy CMO Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Commercial
5.2.2 Academic Research
5.2.3 Others
5.3 Market Segment by Application
5.3.1 World Cell Therapy CMO Market Size by Application (2017-2022)
5.3.2 World Cell Therapy CMO Market Size by Application (2023-2028)
5.3.3 World Cell Therapy CMO Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Charles River
6.1.1 Charles River Details
6.1.2 Charles River Major Business
6.1.3 Charles River Cell Therapy CMO Product and Services
6.1.4 Charles River Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Charles River Recent Developments/Updates
6.1.6 Charles River Competitive Strengths & Weaknesses
6.2 The Discovery Labs
6.2.1 The Discovery Labs Details
6.2.2 The Discovery Labs Major Business
6.2.3 The Discovery Labs Cell Therapy CMO Product and Services
6.2.4 The Discovery Labs Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 The Discovery Labs Recent Developments/Updates
6.2.6 The Discovery Labs Competitive Strengths & Weaknesses
6.3 BIOCENTRIQ
6.3.1 BIOCENTRIQ Details
6.3.2 BIOCENTRIQ Major Business
6.3.3 BIOCENTRIQ Cell Therapy CMO Product and Services
6.3.4 BIOCENTRIQ Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 BIOCENTRIQ Recent Developments/Updates
6.3.6 BIOCENTRIQ Competitive Strengths & Weaknesses
6.4 FUJIFILM Diosynth Biotechnologies
6.4.1 FUJIFILM Diosynth Biotechnologies Details
6.4.2 FUJIFILM Diosynth Biotechnologies Major Business
6.4.3 FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Product and Services
6.4.4 FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
6.4.6 FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
6.5 Exothera
6.5.1 Exothera Details
6.5.2 Exothera Major Business
6.5.3 Exothera Cell Therapy CMO Product and Services
6.5.4 Exothera Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Exothera Recent Developments/Updates
6.5.6 Exothera Competitive Strengths & Weaknesses
6.6 WuXi AppTec
6.6.1 WuXi AppTec Details
6.6.2 WuXi AppTec Major Business
6.6.3 WuXi AppTec Cell Therapy CMO Product and Services
6.6.4 WuXi AppTec Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 WuXi AppTec Recent Developments/Updates
6.6.6 WuXi AppTec Competitive Strengths & Weaknesses
6.7 Pharmaron
6.7.1 Pharmaron Details
6.7.2 Pharmaron Major Business
6.7.3 Pharmaron Cell Therapy CMO Product and Services
6.7.4 Pharmaron Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 Pharmaron Recent Developments/Updates
6.7.6 Pharmaron Competitive Strengths & Weaknesses
6.8 OBiO
6.8.1 OBiO Details
6.8.2 OBiO Major Business
6.8.3 OBiO Cell Therapy CMO Product and Services
6.8.4 OBiO Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 OBiO Recent Developments/Updates
6.8.6 OBiO Competitive Strengths & Weaknesses
6.9 Cell Therapies
6.9.1 Cell Therapies Details
6.9.2 Cell Therapies Major Business
6.9.3 Cell Therapies Cell Therapy CMO Product and Services
6.9.4 Cell Therapies Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 Cell Therapies Recent Developments/Updates
6.9.6 Cell Therapies Competitive Strengths & Weaknesses
6.10 AGC Biologics
6.10.1 AGC Biologics Details
6.10.2 AGC Biologics Major Business
6.10.3 AGC Biologics Cell Therapy CMO Product and Services
6.10.4 AGC Biologics Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 AGC Biologics Recent Developments/Updates
6.10.6 AGC Biologics Competitive Strengths & Weaknesses
6.11 Cytiva
6.11.1 Cytiva Details
6.11.2 Cytiva Major Business
6.11.3 Cytiva Cell Therapy CMO Product and Services
6.11.4 Cytiva Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 Cytiva Recent Developments/Updates
6.11.6 Cytiva Competitive Strengths & Weaknesses
6.12 Helixmith
6.12.1 Helixmith Details
6.12.2 Helixmith Major Business
6.12.3 Helixmith Cell Therapy CMO Product and Services
6.12.4 Helixmith Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 Helixmith Recent Developments/Updates
6.12.6 Helixmith Competitive Strengths & Weaknesses
6.13 ThermoGenesis
6.13.1 ThermoGenesis Details
6.13.2 ThermoGenesis Major Business
6.13.3 ThermoGenesis Cell Therapy CMO Product and Services
6.13.4 ThermoGenesis Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 ThermoGenesis Recent Developments/Updates
6.13.6 ThermoGenesis Competitive Strengths & Weaknesses
6.14 Anemocyte
6.14.1 Anemocyte Details
6.14.2 Anemocyte Major Business
6.14.3 Anemocyte Cell Therapy CMO Product and Services
6.14.4 Anemocyte Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 Anemocyte Recent Developments/Updates
6.14.6 Anemocyte Competitive Strengths & Weaknesses
6.15 Thermo Fisher Scientific
6.15.1 Thermo Fisher Scientific Details
6.15.2 Thermo Fisher Scientific Major Business
6.15.3 Thermo Fisher Scientific Cell Therapy CMO Product and Services
6.15.4 Thermo Fisher Scientific Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 Thermo Fisher Scientific Recent Developments/Updates
6.15.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
6.16 CBM
6.16.1 CBM Details
6.16.2 CBM Major Business
6.16.3 CBM Cell Therapy CMO Product and Services
6.16.4 CBM Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.16.5 CBM Recent Developments/Updates
6.16.6 CBM Competitive Strengths & Weaknesses
6.17 Bio Elpida
6.17.1 Bio Elpida Details
6.17.2 Bio Elpida Major Business
6.17.3 Bio Elpida Cell Therapy CMO Product and Services
6.17.4 Bio Elpida Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.17.5 Bio Elpida Recent Developments/Updates
6.17.6 Bio Elpida Competitive Strengths & Weaknesses
6.18 Genezen
6.18.1 Genezen Details
6.18.2 Genezen Major Business
6.18.3 Genezen Cell Therapy CMO Product and Services
6.18.4 Genezen Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.18.5 Genezen Recent Developments/Updates
6.18.6 Genezen Competitive Strengths & Weaknesses
6.19 CCRM
6.19.1 CCRM Details
6.19.2 CCRM Major Business
6.19.3 CCRM Cell Therapy CMO Product and Services
6.19.4 CCRM Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.19.5 CCRM Recent Developments/Updates
6.19.6 CCRM Competitive Strengths & Weaknesses
6.20 RoslinCT
6.20.1 RoslinCT Details
6.20.2 RoslinCT Major Business
6.20.3 RoslinCT Cell Therapy CMO Product and Services
6.20.4 RoslinCT Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.20.5 RoslinCT Recent Developments/Updates
6.20.6 RoslinCT Competitive Strengths & Weaknesses
6.21 GenScript ProBio
6.21.1 GenScript ProBio Details
6.21.2 GenScript ProBio Major Business
6.21.3 GenScript ProBio Cell Therapy CMO Product and Services
6.21.4 GenScript ProBio Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022)
6.21.5 GenScript ProBio Recent Developments/Updates
6.21.6 GenScript ProBio Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Cell Therapy CMO and Key Manufacturers
7.2 Cell Therapy CMO Manufacturing Costs
7.3 Cell Therapy CMO Production Process
7.4 Cell Therapy CMO Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Cell Therapy CMO Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Cell Therapy CMO Typical Distributors
8.3 Cell Therapy CMO Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Cell Therapy CMO Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Cell Therapy CMO Market Size by Region (2017-2022) & (USD Million)
Table 3. World Cell Therapy CMO Market Size by Region (2023-2028) & (USD Million)
Table 4. World Cell Therapy CMO Market Size Market Share by Region (2017-2022)
Table 5. World Cell Therapy CMO Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Cell Therapy CMO Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Cell Therapy CMO Players in 2021
Table 9. World Cell Therapy CMO Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Cell Therapy CMO Company Evaluation Quadrant
Table 11. Head Office of Key Cell Therapy CMO Player
Table 12. Cell Therapy CMO Market: Company Product Type Footprint
Table 13. Cell Therapy CMO Market: Company Product Application Footprint
Table 14. Cell Therapy CMO Mergers & Acquisitions Activity
Table 15. United States VS China Cell Therapy CMO Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Cell Therapy CMO in United States, Headquarters (States, Country)
Table 17. United States Cell Therapy CMO Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Cell Therapy CMO Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Cell Therapy CMO in China, Company Headquarters (Province, Country)
Table 20. China Cell Therapy CMO Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Cell Therapy CMO Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Cell Therapy CMO in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Cell Therapy CMO Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Cell Therapy CMO Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Cell Therapy CMO Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Cell Therapy CMO Revenue by Type (2017-2022) & (USD Million)
Table 27. World Cell Therapy CMO Revenue by Type (2023-2028) & (USD Million)
Table 28. World Cell Therapy CMO Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Cell Therapy CMO Revenue by Application (2017-2022) & (USD Million)
Table 30. World Cell Therapy CMO Revenue by Application (2023-2028) & (USD Million)
Table 31. Charles River Basic Information, Area Served and Competitors
Table 32. Charles River Major Business
Table 33. Charles River Cell Therapy CMO Product and Services
Table 34. Charles River Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Charles River Recent Developments/Updates
Table 36. Charles River Competitive Strengths & Weaknesses
Table 37. The Discovery Labs Basic Information, Area Served and Competitors
Table 38. The Discovery Labs Major Business
Table 39. The Discovery Labs Cell Therapy CMO Product and Services
Table 40. The Discovery Labs Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. The Discovery Labs Recent Developments/Updates
Table 42. The Discovery Labs Competitive Strengths & Weaknesses
Table 43. BIOCENTRIQ Basic Information, Area Served and Competitors
Table 44. BIOCENTRIQ Major Business
Table 45. BIOCENTRIQ Cell Therapy CMO Product and Services
Table 46. BIOCENTRIQ Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. BIOCENTRIQ Recent Developments/Updates
Table 48. BIOCENTRIQ Competitive Strengths & Weaknesses
Table 49. FUJIFILM Diosynth Biotechnologies Basic Information, Area Served and Competitors
Table 50. FUJIFILM Diosynth Biotechnologies Major Business
Table 51. FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Product and Services
Table 52. FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
Table 54. FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
Table 55. Exothera Basic Information, Area Served and Competitors
Table 56. Exothera Major Business
Table 57. Exothera Cell Therapy CMO Product and Services
Table 58. Exothera Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Exothera Recent Developments/Updates
Table 60. Exothera Competitive Strengths & Weaknesses
Table 61. WuXi AppTec Basic Information, Area Served and Competitors
Table 62. WuXi AppTec Major Business
Table 63. WuXi AppTec Cell Therapy CMO Product and Services
Table 64. WuXi AppTec Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. WuXi AppTec Recent Developments/Updates
Table 66. WuXi AppTec Competitive Strengths & Weaknesses
Table 67. Pharmaron Basic Information, Area Served and Competitors
Table 68. Pharmaron Major Business
Table 69. Pharmaron Cell Therapy CMO Product and Services
Table 70. Pharmaron Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Pharmaron Recent Developments/Updates
Table 72. Pharmaron Competitive Strengths & Weaknesses
Table 73. OBiO Basic Information, Area Served and Competitors
Table 74. OBiO Major Business
Table 75. OBiO Cell Therapy CMO Product and Services
Table 76. OBiO Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. OBiO Recent Developments/Updates
Table 78. OBiO Competitive Strengths & Weaknesses
Table 79. Cell Therapies Basic Information, Area Served and Competitors
Table 80. Cell Therapies Major Business
Table 81. Cell Therapies Cell Therapy CMO Product and Services
Table 82. Cell Therapies Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. Cell Therapies Recent Developments/Updates
Table 84. Cell Therapies Competitive Strengths & Weaknesses
Table 85. AGC Biologics Basic Information, Area Served and Competitors
Table 86. AGC Biologics Major Business
Table 87. AGC Biologics Cell Therapy CMO Product and Services
Table 88. AGC Biologics Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. AGC Biologics Recent Developments/Updates
Table 90. AGC Biologics Competitive Strengths & Weaknesses
Table 91. Cytiva Basic Information, Area Served and Competitors
Table 92. Cytiva Major Business
Table 93. Cytiva Cell Therapy CMO Product and Services
Table 94. Cytiva Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. Cytiva Recent Developments/Updates
Table 96. Cytiva Competitive Strengths & Weaknesses
Table 97. Helixmith Basic Information, Area Served and Competitors
Table 98. Helixmith Major Business
Table 99. Helixmith Cell Therapy CMO Product and Services
Table 100. Helixmith Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. Helixmith Recent Developments/Updates
Table 102. Helixmith Competitive Strengths & Weaknesses
Table 103. ThermoGenesis Basic Information, Area Served and Competitors
Table 104. ThermoGenesis Major Business
Table 105. ThermoGenesis Cell Therapy CMO Product and Services
Table 106. ThermoGenesis Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. ThermoGenesis Recent Developments/Updates
Table 108. ThermoGenesis Competitive Strengths & Weaknesses
Table 109. Anemocyte Basic Information, Area Served and Competitors
Table 110. Anemocyte Major Business
Table 111. Anemocyte Cell Therapy CMO Product and Services
Table 112. Anemocyte Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. Anemocyte Recent Developments/Updates
Table 114. Anemocyte Competitive Strengths & Weaknesses
Table 115. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 116. Thermo Fisher Scientific Major Business
Table 117. Thermo Fisher Scientific Cell Therapy CMO Product and Services
Table 118. Thermo Fisher Scientific Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 119. Thermo Fisher Scientific Recent Developments/Updates
Table 120. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 121. CBM Basic Information, Area Served and Competitors
Table 122. CBM Major Business
Table 123. CBM Cell Therapy CMO Product and Services
Table 124. CBM Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 125. CBM Recent Developments/Updates
Table 126. CBM Competitive Strengths & Weaknesses
Table 127. Bio Elpida Basic Information, Area Served and Competitors
Table 128. Bio Elpida Major Business
Table 129. Bio Elpida Cell Therapy CMO Product and Services
Table 130. Bio Elpida Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 131. Bio Elpida Recent Developments/Updates
Table 132. Bio Elpida Competitive Strengths & Weaknesses
Table 133. Genezen Basic Information, Area Served and Competitors
Table 134. Genezen Major Business
Table 135. Genezen Cell Therapy CMO Product and Services
Table 136. Genezen Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 137. Genezen Recent Developments/Updates
Table 138. Genezen Competitive Strengths & Weaknesses
Table 139. CCRM Basic Information, Area Served and Competitors
Table 140. CCRM Major Business
Table 141. CCRM Cell Therapy CMO Product and Services
Table 142. CCRM Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 143. CCRM Recent Developments/Updates
Table 144. CCRM Competitive Strengths & Weaknesses
Table 145. RoslinCT Basic Information, Area Served and Competitors
Table 146. RoslinCT Major Business
Table 147. RoslinCT Cell Therapy CMO Product and Services
Table 148. RoslinCT Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 149. RoslinCT Recent Developments/Updates
Table 150. GenScript ProBio Basic Information, Area Served and Competitors
Table 151. GenScript ProBio Major Business
Table 152. GenScript ProBio Cell Therapy CMO Product and Services
Table 153. GenScript ProBio Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 154. Cell Therapy CMO Raw Material
Table 155. Key Manufacturers of Cell Therapy CMO Raw Materials
Table 156. Cell Therapy CMO Typical Distributors
Table 157. Cell Therapy CMO Typical Customers
Table 1. World Cell Therapy CMO Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Cell Therapy CMO Market Size by Region (2017-2022) & (USD Million)
Table 3. World Cell Therapy CMO Market Size by Region (2023-2028) & (USD Million)
Table 4. World Cell Therapy CMO Market Size Market Share by Region (2017-2022)
Table 5. World Cell Therapy CMO Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Cell Therapy CMO Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Cell Therapy CMO Players in 2021
Table 9. World Cell Therapy CMO Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Cell Therapy CMO Company Evaluation Quadrant
Table 11. Head Office of Key Cell Therapy CMO Player
Table 12. Cell Therapy CMO Market: Company Product Type Footprint
Table 13. Cell Therapy CMO Market: Company Product Application Footprint
Table 14. Cell Therapy CMO Mergers & Acquisitions Activity
Table 15. United States VS China Cell Therapy CMO Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Cell Therapy CMO in United States, Headquarters (States, Country)
Table 17. United States Cell Therapy CMO Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Cell Therapy CMO Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Cell Therapy CMO in China, Company Headquarters (Province, Country)
Table 20. China Cell Therapy CMO Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Cell Therapy CMO Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Cell Therapy CMO in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Cell Therapy CMO Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Cell Therapy CMO Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Cell Therapy CMO Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Cell Therapy CMO Revenue by Type (2017-2022) & (USD Million)
Table 27. World Cell Therapy CMO Revenue by Type (2023-2028) & (USD Million)
Table 28. World Cell Therapy CMO Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Cell Therapy CMO Revenue by Application (2017-2022) & (USD Million)
Table 30. World Cell Therapy CMO Revenue by Application (2023-2028) & (USD Million)
Table 31. Charles River Basic Information, Area Served and Competitors
Table 32. Charles River Major Business
Table 33. Charles River Cell Therapy CMO Product and Services
Table 34. Charles River Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Charles River Recent Developments/Updates
Table 36. Charles River Competitive Strengths & Weaknesses
Table 37. The Discovery Labs Basic Information, Area Served and Competitors
Table 38. The Discovery Labs Major Business
Table 39. The Discovery Labs Cell Therapy CMO Product and Services
Table 40. The Discovery Labs Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. The Discovery Labs Recent Developments/Updates
Table 42. The Discovery Labs Competitive Strengths & Weaknesses
Table 43. BIOCENTRIQ Basic Information, Area Served and Competitors
Table 44. BIOCENTRIQ Major Business
Table 45. BIOCENTRIQ Cell Therapy CMO Product and Services
Table 46. BIOCENTRIQ Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. BIOCENTRIQ Recent Developments/Updates
Table 48. BIOCENTRIQ Competitive Strengths & Weaknesses
Table 49. FUJIFILM Diosynth Biotechnologies Basic Information, Area Served and Competitors
Table 50. FUJIFILM Diosynth Biotechnologies Major Business
Table 51. FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Product and Services
Table 52. FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
Table 54. FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
Table 55. Exothera Basic Information, Area Served and Competitors
Table 56. Exothera Major Business
Table 57. Exothera Cell Therapy CMO Product and Services
Table 58. Exothera Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Exothera Recent Developments/Updates
Table 60. Exothera Competitive Strengths & Weaknesses
Table 61. WuXi AppTec Basic Information, Area Served and Competitors
Table 62. WuXi AppTec Major Business
Table 63. WuXi AppTec Cell Therapy CMO Product and Services
Table 64. WuXi AppTec Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. WuXi AppTec Recent Developments/Updates
Table 66. WuXi AppTec Competitive Strengths & Weaknesses
Table 67. Pharmaron Basic Information, Area Served and Competitors
Table 68. Pharmaron Major Business
Table 69. Pharmaron Cell Therapy CMO Product and Services
Table 70. Pharmaron Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Pharmaron Recent Developments/Updates
Table 72. Pharmaron Competitive Strengths & Weaknesses
Table 73. OBiO Basic Information, Area Served and Competitors
Table 74. OBiO Major Business
Table 75. OBiO Cell Therapy CMO Product and Services
Table 76. OBiO Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. OBiO Recent Developments/Updates
Table 78. OBiO Competitive Strengths & Weaknesses
Table 79. Cell Therapies Basic Information, Area Served and Competitors
Table 80. Cell Therapies Major Business
Table 81. Cell Therapies Cell Therapy CMO Product and Services
Table 82. Cell Therapies Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. Cell Therapies Recent Developments/Updates
Table 84. Cell Therapies Competitive Strengths & Weaknesses
Table 85. AGC Biologics Basic Information, Area Served and Competitors
Table 86. AGC Biologics Major Business
Table 87. AGC Biologics Cell Therapy CMO Product and Services
Table 88. AGC Biologics Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. AGC Biologics Recent Developments/Updates
Table 90. AGC Biologics Competitive Strengths & Weaknesses
Table 91. Cytiva Basic Information, Area Served and Competitors
Table 92. Cytiva Major Business
Table 93. Cytiva Cell Therapy CMO Product and Services
Table 94. Cytiva Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. Cytiva Recent Developments/Updates
Table 96. Cytiva Competitive Strengths & Weaknesses
Table 97. Helixmith Basic Information, Area Served and Competitors
Table 98. Helixmith Major Business
Table 99. Helixmith Cell Therapy CMO Product and Services
Table 100. Helixmith Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. Helixmith Recent Developments/Updates
Table 102. Helixmith Competitive Strengths & Weaknesses
Table 103. ThermoGenesis Basic Information, Area Served and Competitors
Table 104. ThermoGenesis Major Business
Table 105. ThermoGenesis Cell Therapy CMO Product and Services
Table 106. ThermoGenesis Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. ThermoGenesis Recent Developments/Updates
Table 108. ThermoGenesis Competitive Strengths & Weaknesses
Table 109. Anemocyte Basic Information, Area Served and Competitors
Table 110. Anemocyte Major Business
Table 111. Anemocyte Cell Therapy CMO Product and Services
Table 112. Anemocyte Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. Anemocyte Recent Developments/Updates
Table 114. Anemocyte Competitive Strengths & Weaknesses
Table 115. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 116. Thermo Fisher Scientific Major Business
Table 117. Thermo Fisher Scientific Cell Therapy CMO Product and Services
Table 118. Thermo Fisher Scientific Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 119. Thermo Fisher Scientific Recent Developments/Updates
Table 120. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 121. CBM Basic Information, Area Served and Competitors
Table 122. CBM Major Business
Table 123. CBM Cell Therapy CMO Product and Services
Table 124. CBM Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 125. CBM Recent Developments/Updates
Table 126. CBM Competitive Strengths & Weaknesses
Table 127. Bio Elpida Basic Information, Area Served and Competitors
Table 128. Bio Elpida Major Business
Table 129. Bio Elpida Cell Therapy CMO Product and Services
Table 130. Bio Elpida Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 131. Bio Elpida Recent Developments/Updates
Table 132. Bio Elpida Competitive Strengths & Weaknesses
Table 133. Genezen Basic Information, Area Served and Competitors
Table 134. Genezen Major Business
Table 135. Genezen Cell Therapy CMO Product and Services
Table 136. Genezen Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 137. Genezen Recent Developments/Updates
Table 138. Genezen Competitive Strengths & Weaknesses
Table 139. CCRM Basic Information, Area Served and Competitors
Table 140. CCRM Major Business
Table 141. CCRM Cell Therapy CMO Product and Services
Table 142. CCRM Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 143. CCRM Recent Developments/Updates
Table 144. CCRM Competitive Strengths & Weaknesses
Table 145. RoslinCT Basic Information, Area Served and Competitors
Table 146. RoslinCT Major Business
Table 147. RoslinCT Cell Therapy CMO Product and Services
Table 148. RoslinCT Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 149. RoslinCT Recent Developments/Updates
Table 150. GenScript ProBio Basic Information, Area Served and Competitors
Table 151. GenScript ProBio Major Business
Table 152. GenScript ProBio Cell Therapy CMO Product and Services
Table 153. GenScript ProBio Cell Therapy CMO Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 154. Cell Therapy CMO Raw Material
Table 155. Key Manufacturers of Cell Therapy CMO Raw Materials
Table 156. Cell Therapy CMO Typical Distributors
Table 157. Cell Therapy CMO Typical Customers
LIST OF FIGURES
Figure 1. Cell Therapy CMO Picture
Figure 2. World Cell Therapy CMO Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Cell Therapy CMO Total Market Size (2017-2028) & (USD Million)
Figure 4. World Cell Therapy CMO Market Size Market Share by Region (2017-2028)
Figure 5. United States Cell Therapy CMO Market Size (2017-2028) & (USD Million)
Figure 6. China Cell Therapy CMO Market Size (2017-2028) & (USD Million)
Figure 7. Europe Cell Therapy CMO Market Size (2017-2028) & (USD Million)
Figure 8. Japan Cell Therapy CMO Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Cell Therapy CMO Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Cell Therapy CMO Market Size (2017-2028) & (USD Million)
Figure 11. India Cell Therapy CMO Market Size (2017-2028) & (USD Million)
Figure 12. Cell Therapy CMO Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Cell Therapy CMO by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Cell Therapy CMO Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Cell Therapy CMO Markets in 2021
Figure 17. United States VS China: Cell Therapy CMO Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Cell Therapy CMO Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Cell Therapy CMO Market Size Market Share by Type in 2021
Figure 20. Stem Cell
Figure 21. Non-Stem Cell
Figure 22. World Cell Therapy CMO Market Size Market Share by Type (2017-2028)
Figure 23. World Cell Therapy CMO Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 24. World Cell Therapy CMO Market Size Market Share by Application in 2021
Figure 25. Commercial
Figure 26. Academic Research
Figure 27. Others
Figure 28. World Cell Therapy CMO Market Size Market Share by Application (2017-2028)
Figure 29. Manufacturing Cost Structure Analysis of Cell Therapy CMO in 2021
Figure 30. Manufacturing Process Analysis of Cell Therapy CMO
Figure 31. Cell Therapy CMO Industrial Chain
Figure 32. Distribution Channel Breakdown for Cell Therapy CMO Shipments (%): 2017-2028
Figure 33. Direct Channel Pros & Cons
Figure 34. Indirect Channel Pros & Cons
Figure 35. Methodology
Figure 36. Research Process and Data Source
Figure 1. Cell Therapy CMO Picture
Figure 2. World Cell Therapy CMO Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Cell Therapy CMO Total Market Size (2017-2028) & (USD Million)
Figure 4. World Cell Therapy CMO Market Size Market Share by Region (2017-2028)
Figure 5. United States Cell Therapy CMO Market Size (2017-2028) & (USD Million)
Figure 6. China Cell Therapy CMO Market Size (2017-2028) & (USD Million)
Figure 7. Europe Cell Therapy CMO Market Size (2017-2028) & (USD Million)
Figure 8. Japan Cell Therapy CMO Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Cell Therapy CMO Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Cell Therapy CMO Market Size (2017-2028) & (USD Million)
Figure 11. India Cell Therapy CMO Market Size (2017-2028) & (USD Million)
Figure 12. Cell Therapy CMO Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Cell Therapy CMO by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Cell Therapy CMO Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Cell Therapy CMO Markets in 2021
Figure 17. United States VS China: Cell Therapy CMO Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Cell Therapy CMO Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Cell Therapy CMO Market Size Market Share by Type in 2021
Figure 20. Stem Cell
Figure 21. Non-Stem Cell
Figure 22. World Cell Therapy CMO Market Size Market Share by Type (2017-2028)
Figure 23. World Cell Therapy CMO Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 24. World Cell Therapy CMO Market Size Market Share by Application in 2021
Figure 25. Commercial
Figure 26. Academic Research
Figure 27. Others
Figure 28. World Cell Therapy CMO Market Size Market Share by Application (2017-2028)
Figure 29. Manufacturing Cost Structure Analysis of Cell Therapy CMO in 2021
Figure 30. Manufacturing Process Analysis of Cell Therapy CMO
Figure 31. Cell Therapy CMO Industrial Chain
Figure 32. Distribution Channel Breakdown for Cell Therapy CMO Shipments (%): 2017-2028
Figure 33. Direct Channel Pros & Cons
Figure 34. Indirect Channel Pros & Cons
Figure 35. Methodology
Figure 36. Research Process and Data Source
